Michael P. Veve

1.7k total citations
76 papers, 925 citations indexed

About

Michael P. Veve is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Michael P. Veve has authored 76 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 25 papers in Epidemiology and 22 papers in Applied Microbiology and Biotechnology. Recurrent topics in Michael P. Veve's work include Antibiotic Use and Resistance (22 papers), Antibiotic Resistance in Bacteria (19 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Michael P. Veve is often cited by papers focused on Antibiotic Use and Resistance (22 papers), Antibiotic Resistance in Bacteria (19 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Michael P. Veve collaborates with scholars based in United States, Jordan and Canada. Michael P. Veve's co-authors include Jamie L. Wagner, Susan L. Davis, Mahmoud Shorman, Nimish Patel, Rachel M. Kenney, Keith S. Kaye, Michael J. Rybak, Anthony T. Gerlach, Laura Puzniak and Twisha S Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Michael P. Veve

59 papers receiving 908 citations

Peers

Michael P. Veve
Maristela Pinheiro Freire Brazil
Yi Ling Lai United States
Rupali Jain United States
Jamie L. Wagner United States
Anna Maria Peri Italy
Melinda K. Lacy United States
Rajeev Soman India
Shellee A. Grim United States
Abdalhamid M Lagnf United States
Béatrice Grabein Germany
Maristela Pinheiro Freire Brazil
Michael P. Veve
Citations per year, relative to Michael P. Veve Michael P. Veve (= 1×) peers Maristela Pinheiro Freire

Countries citing papers authored by Michael P. Veve

Since Specialization
Citations

This map shows the geographic impact of Michael P. Veve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Veve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Veve more than expected).

Fields of papers citing papers by Michael P. Veve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Veve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Veve. The network helps show where Michael P. Veve may publish in the future.

Co-authorship network of co-authors of Michael P. Veve

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Veve. A scholar is included among the top collaborators of Michael P. Veve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Veve. Michael P. Veve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kenney, Rachel M., et al.. (2025). P-1410. Oral Antimicrobial Therapy Offers in Hospitalized Persons Who Inject Drugs who Elect for Self-directed Discharge. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Kenney, Rachel M., et al.. (2025). P-2312. Impact of a Short Course Post-Operative Antibiotic Prophylaxis Duration on Nephrotoxicity in Lung Transplant Recipients. Open Forum Infectious Diseases. 12(Supplement_1).
3.
Veve, Michael P., George Alangaden, Kimberly C. Claeys, et al.. (2025). Evaluating antimicrobial stewardship strategies in candidemia: a novel desirability of outcome ranking (DOOR) analysis comparing blood culture versus T2Candida diagnostic approaches. Journal of Clinical Microbiology. 63(5). e0004325–e0004325. 1 indexed citations
4.
5.
Shallal, Anita, Michael P. Veve, Rachel M. Kenney, George Alangaden, & Geehan Suleyman. (2024). Characterisation, management, and outcomes of New Delhi metallo-β-lactamase-producing Escherichia coli: A case series. Journal of Global Antimicrobial Resistance. 40. 42–46.
6.
7.
Veve, Michael P., et al.. (2024). Navigating performance measures for ambulatory antimicrobial stewardship: a review of HEDIS® and other metrics the steward should know. SHILAP Revista de lepidopterología. 4(1). e217–e217.
8.
9.
10.
Kenney, Rachel M., et al.. (2024). Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection. International Journal of Infectious Diseases. 151. 107314–107314.
11.
Kenney, Rachel M., et al.. (2023). Respiratory culture nudge improves antibiotic prescribing for Moraxella catarrhalis and Haemophilus influenzae lower respiratory tract infections. SHILAP Revista de lepidopterología. 3(1). e23–e23. 6 indexed citations
12.
Coyne, Ashlan J. Kunz, et al.. (2023). Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese. Open Forum Infectious Diseases. 10(9). ofad454–ofad454. 1 indexed citations
13.
Coyne, Ashlan J. Kunz, Amer El Ghali, Nicholas Rebold, et al.. (2023). High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open Forum Infectious Diseases. 10(3). ofad034–ofad034. 15 indexed citations
14.
15.
16.
Veve, Michael P., et al.. (2022). Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections. Open Forum Infectious Diseases. 9(7). ofac297–ofac297. 16 indexed citations
17.
Morrisette, Taylor, Sara Alosaimy, Abdalhamid M Lagnf, et al.. (2022). Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens. Infectious Diseases and Therapy. 11(4). 1715–1723. 12 indexed citations
18.
Hamilton, Leslie A., et al.. (2022). Antibiotic Prophylaxis and Incidence of Infection with External Ventricular Drains and Intra-Cranial Pressure Monitors. Surgical Infections. 23(3). 262–269. 4 indexed citations
19.
Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2021). Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open Forum Infectious Diseases. 9(3). ofab606–ofab606. 18 indexed citations
20.
Veve, Michael P., et al.. (2020). Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. International Journal of Antimicrobial Agents. 56(6). 106210–106210. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maristela Pinheiro Freire Breakdown of academic impact, for papers by Yi Ling Lai Breakdown of academic impact, for papers by Rupali Jain Breakdown of academic impact, for papers by Jamie L. Wagner Breakdown of academic impact, for papers by Anna Maria Peri Breakdown of academic impact, for papers by Melinda K. Lacy Breakdown of academic impact, for papers by Rajeev Soman Breakdown of academic impact, for papers by Shellee A. Grim Breakdown of academic impact, for papers by Abdalhamid M Lagnf Breakdown of academic impact, for papers by Béatrice Grabein
Rankless by CCL
2026